Fetal growth and placental function assessed by urinary estriol excretion before the onset of pre-eclampsia.
In a series of 1,316 patients with pre-eclampsia 744 had urinary estriol excretion measured before and 366 after the onset of clinical signs of the disease. Low estriol excretion had a highly significant association with fetal growth retardation and perinatal death both before and after the onset of clinical signs (p less than 0.001). As assessed by the incidences of low estriol excretion, fetal growth retardation, and perinatal wastage, pre-eclampsia of early onset (before 37 weeks) was a malignant disease in comparison with pre-eclampsia of late onset (after 37 weeks). Patients destined to develop early-onset pre-eclampsia had a high incidence of subnormal estriol excretion (25.4%; p less than 0.001). Although further deterioration of placental function occurred after the onset of clinical signs (41.3%; p less than 0.01), fetal growth and prognosis were already determined.
D004964:Estriol / Q000652:urine*; D005260:Female; D005317:Fetal Growth Retardation / Q000150:complications*; D005865:Gestational Age; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D010925:Placental Function Tests / Q000379:methods; D011225:Pre-Eclampsia / Q000150:complications / Q000652:urine*; D011247:Pregnancy; D013997:Time Factors
D004964:Estriol